Showing results (1041-1050 of 1,649) with videos related to
Sort By:
Pageof 165
Clinical and Translational Medicine|January 5, 2017
A current perspective on cancer immune therapy: step-by-step approach to constructing the magic bulletGabriele D'Errico, Heather L Machado, Bruno SainzClinical and Translational Medicine|April 14, 2017
Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathwayYves Lecarpentier, Victor Claes, Alexandre Vallée, et al.Clinical and Translational Medicine|January 20, 2017
Tissue is the issue and tissue competition. Re-biopsy for mutation T790: where and why?Paul Zarogoulidis, Mina Gaga, Haidong Huang, et al.Clinical and Translational Medicine|January 28, 2015
Lung flute improves symptoms and health status in COPD with chronic bronchitis: A 26 week randomized controlled trialSanjay Sethi, Jingjing Yin, Pamela K AndersonClinical and Translational Medicine|July 31, 2022
The driver role of JAK-STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy- and castration-resistant prostate cancerU-Ging Lo, Yu-An Chen, Junjie Cen, et al.Clinical and Translational Medicine|July 31, 2022
CD47-SIRPα blocking-based immunotherapy: Current and prospective therapeutic strategiesRenée Bouwstra, Tom van Meerten, Edwin BremerClinical and Translational Medicine|July 20, 2022
Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancerLin Shi, Weiliang Zhu, Yuanyuan Huang, et al.Clinical and Translational Medicine|April 13, 2022
LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non-small cell lung cancerYanping Gao, Nannan Zhang, Zihang Zeng, et al.Clinical and Translational Medicine|January 28, 2022
Study on feasibility of the partial meniscal allograft transplantationBao-Shi Fan, Jing Ye, Bing-Bing Xu, et al.Clinical and Translational Medicine|January 28, 2022
Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple-negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 betaYunting Jian, Lingzhi Kong, Hongyi Xu, et al.Pageof 165